Skip to content
Pullman, WA · 560 SE Bishop Blvd·Mon–Fri 8:00–5:00
(509) 334-3300·Contact·Pay my Bill →

In-Office Treatment at 560 SE Bishop Blvd · Pullman, WA

Valeda® light therapy for dry macular degeneration, right here in Pullman.

Our Pullman clinic is home to the Palouse’s FDA-authorized Valeda® Light Delivery System. For patients with early-to-intermediate dry age-related macular degeneration, Valeda offers a gentle, 5-minute in-office treatment proven to improve vision and covered by Medicare.

Pullman Hub Our practice’s Valeda® Light Delivery System is physically installed at our 560 SE Bishop Blvd clinic in Pullman, serving patients from across Whitman and Latah counties.
84% of patients treated in the two-year LIGHTSITE III trial improved or maintained their visual acuity, with more than 60% gaining at least one full line of letters on the eye chart.
Medicare covers Valeda® photobiomodulation for qualifying patients with dry AMD. Every 5-minute session is non-invasive, with no injections and no pupil dilation.

Why Pullman is the regional destination for dry AMD therapy

Nearly nine out of ten people diagnosed with age-related macular degeneration have the dry form. In dry AMD, the metabolically active support cells beneath the center of your retina gradually slow down, allowing yellow lipid-protein deposits called drusen to accumulate and dim your straight-ahead reading and driving vision.

For decades, the only advice available for early or intermediate dry AMD was to take AREDS2 vitamins, wear sunglasses, and hope the condition didn’t progress to wet AMD or late-stage geographic atrophy. Active treatment didn’t exist until advanced vision loss had already begun.

With FDA De Novo authorization of the Valeda® Light Delivery System, we can now intervene early, while you still have strong central vision worth protecting. And because our practice installed the Valeda system right here in our Pullman clinic on Bishop Boulevard, every treatment session takes place in our Pullman office.

Side-by-side retinal photographs of a patient treated in our Pullman clinic before and after a series of Valeda photobiomodulation sessions, showing marked reduction in drusen deposits
Before-and-after retinal photographs from one of our own patients treated at our Pullman clinic, demonstrating a visible reduction in macular drusen following Valeda® therapy.

How multi-wavelength photobiomodulation recharges retinal cells

The macula has one of the highest metabolic rates of any tissue in the body. Inside each retinal pigment epithelial (RPE) and photoreceptor cell, microscopic organelles called mitochondria work around the clock to produce ATP, the cellular energy required to process light and clear away cellular waste.

As dry AMD develops, mitochondrial efficiency drops, oxidative stress rises, and waste products collect as drusen. Valeda uses photobiomodulation (PBM)—often referred to by patients as “red light therapy” or multi-wavelength light therapy for dry macular degeneration—delivering three calibrated, low-intensity wavelengths of light directly to the macula:

  • 590 nm (Amber/Yellow) & 660 nm (Red): Calm retinal inflammation, reduce oxidative stress, and support healthy microcirculation
  • 850 nm (Near-Infrared): Stimulates cytochrome c oxidase inside the mitochondria to restore ATP energy production and help retinal cells clear metabolic debris

Unlike surgical or thermal eye lasers, Valeda uses gentle, non-thermal light-emitting diodes (LEDs). Nothing touches your eye, tissue is never heated or cut, and zero light-related adverse events were reported across all three multi-center LIGHTSITE clinical trials.

What to expect at your Pullman treatment visits

We designed our Valeda schedule at 560 SE Bishop Blvd to be easy and convenient for both local Pullman residents and patients driving in from surrounding towns:

9 visits over 3 to 5 weeks
Less than 5 minutes per eye
No dilation: drive yourself home

When you arrive at our Bishop Boulevard office, there are no numbing drops, no needles, and no dilating drops. You simply sit at the Valeda headrest and look toward the light source for a short sequence of open-eye and closed-eye intervals lasting under five minutes per eye. Because your pupils are not dilated, your vision is not blurred afterward and you can drive yourself to and from every session.

Following the clinical protocol proven in the LIGHTSITE III study, each 9-visit series is repeated approximately every 4 to 6 months to sustain cellular energy and visual gains.

Is Valeda right for your eyes?

Valeda is designed for patients who have been diagnosed with early or intermediate dry age-related macular degeneration (characterized by macular drusen or non-central geographic atrophy) and who still have functional central vision (typically between 20/32 and 20/70).

During a comprehensive macular evaluation in Pullman, Dr. Heidi Eiseman, MD, Dr. Alyssa Hoehn, MD, or Dr. Marisa Brown, OD will perform high-resolution OCT macular imaging to map your retinal layers and determine whether your eyes meet the clinical criteria for Valeda therapy.

Medicare & Medical Coverage

Valeda® therapy & macular evaluations covered by Medicare.

Valeda® photobiomodulation is covered by Medicare for qualifying dry AMD patients, and diagnostic macular evaluations are covered by Medicare, Premera, Regence, and major regional medical plans.

  • Medicare
  • Premera Blue Cross
  • Regence BlueShield
  • Blue Cross of Idaho
  • UnitedHealthcare

Our billing specialists confirm your coverage before you start. View all accepted insurance plans → or call (509) 334-3300.

Pullman Valeda® frequently asked questions

Is Valeda the FDA-authorized “red light therapy for dry macular degeneration”?

Yes. Many patients hear Valeda described as “red light therapy for macular degeneration.” Clinically called photobiomodulation (PBM), the FDA-authorized Valeda® Light Delivery System combines three medical-grade wavelengths—590 nm amber, 660 nm red, and 850 nm near-infrared light—specifically calibrated for retinal cells. Unlike consumer red-light panels or masks, which are not safe or calibrated for the human retina, Valeda is an ophthalmic medical device performed in-office under your eye doctor’s supervision.

Are all Valeda treatments done at the Pullman office?

Yes. Our practice’s Valeda® Light Delivery System is housed at Pullman Family Eye Care (560 SE Bishop Blvd, Pullman, WA 99163). Patients from both our Pullman and Moscow clinics, as well as referred patients from Colfax, Lewiston-Clarkston, and across the Inland Northwest, complete their 9-session treatment series right here in Pullman.

Can my regular optometrist refer me to Pullman Family Eye Care just for Valeda?

Absolutely. We frequently partner with optometrists across Eastern Washington and North Idaho. We perform your Valeda evaluation and treatment series in Pullman, send full progress reports to your primary eye doctor, and return you to their office for your ongoing primary vision care.

Should I keep taking my AREDS2 vitamins during Valeda therapy?

Yes. Photobiomodulation and AREDS2 nutritional supplements support the macula in complementary ways. Continue taking any eye vitamins recommended by your doctor alongside your Valeda treatments.

What if one of my eyes has wet AMD and the other has dry AMD?

While an eye with active wet AMD requires anti-VEGF therapy rather than Valeda, your fellow eye with early or intermediate dry AMD is often an ideal candidate for Valeda to help preserve your best reading and driving eye.

How do I schedule a Valeda candidacy evaluation in Pullman?

Call our Pullman office at (509) 334-3300 or request an appointment online.